Respirable aerosol exposures of nicotine dry powder formulations to in vitro, ex vivo, and in vivo pre-clinical models demonstrate consistency of pharmacokinetic …
D Sciuscio, J Hoeng, MC Peitsch… - Inhalation …, 2019 - Taylor & Francis
Background: Nicotine, because of its volatility, has a complex dosimetry following inhalation
as a vapor/aerosol mix. To better control the dosimetry, nicotine could be formulated with a …
as a vapor/aerosol mix. To better control the dosimetry, nicotine could be formulated with a …
[引用][C] Respirable aerosol exposures of nicotine dry powder formulations to in vitro, ex vivo, and in vivo pre-clinical models demonstrate consistency of …
D Sciuscio, J Hoeng, MC Peitsch… - Inhalation …, 2019 - ui.adsabs.harvard.edu
Respirable aerosol exposures of nicotine dry powder formulations to in vitro, ex vivo, and in
vivo pre-clinical models demonstrate consistency of pharmacokinetic profiles - NASA/ADS Now …
vivo pre-clinical models demonstrate consistency of pharmacokinetic profiles - NASA/ADS Now …
Respirable aerosol exposures of nicotine dry powder formulations to in vitro, ex vivo, and in vivo pre-clinical models demonstrate consistency of pharmacokinetic …
D Sciuscio, J Hoeng, MC Peitsch… - Inhalation …, 2019 - search.ebscohost.com
Background: Nicotine, because of its volatility, has a complex dosimetry following inhalation
as a vapor/aerosol mix. To better control the dosimetry, nicotine could be formulated with a …
as a vapor/aerosol mix. To better control the dosimetry, nicotine could be formulated with a …
[PDF][PDF] Respirable aerosol exposures of nicotine dry powder formulations to in vitro, ex vivo, and in vivo pre-clinical models demonstrate consistency of …
D Sciuscio, J Hoeng, MC Peitsch… - INHALATION …, 2019 - researchgate.net
Background: Nicotine, because of its volatility, has a complex dosimetry following inhalation
as a vapor/aerosol mix. To better control the dosimetry, nicotine could be formulated with a …
as a vapor/aerosol mix. To better control the dosimetry, nicotine could be formulated with a …
Respirable aerosol exposures of nicotine dry powder formulations to in vitro, ex vivo, and in vivo pre-clinical models demonstrate consistency of pharmacokinetic …
D Sciuscio, J Hoeng, MC Peitsch… - Inhalation …, 2019 - europepmc.org
Background: Nicotine, because of its volatility, has a complex dosimetry following inhalation
as a vapor/aerosol mix. To better control the dosimetry, nicotine could be formulated with a …
as a vapor/aerosol mix. To better control the dosimetry, nicotine could be formulated with a …
Respirable aerosol exposures of nicotine dry powder formulations to in vitro, ex vivo, and in vivo pre-clinical models demonstrate consistency of pharmacokinetic …
D Sciuscio, J Hoeng, MC Peitsch… - Inhalation …, 2019 - pubmed.ncbi.nlm.nih.gov
Background: Nicotine, because of its volatility, has a complex dosimetry following inhalation
as a vapor/aerosol mix. To better control the dosimetry, nicotine could be formulated with a …
as a vapor/aerosol mix. To better control the dosimetry, nicotine could be formulated with a …